| Authors: |
Balendra R; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, UK; UK Dementia Research Institute at UCL, London, UK. Electronic address: r.balendra@ucl.ac.uk., Sreedharan J; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Hallegger M; UK Dementia Research Institute at King's, London, UK; The Francis Crick Institute, London, UK; Oxford-GSK Institute of Molecular and Computational Medicine, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Luisier R; Genomics and Health Informatics Group, Idiap Research Institute, Martigny, Switzerland., Lashuel HA; Laboratory of Molecular and Chemical Biology of Neurodegeneration, Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Qatar Foundation, Doha, Qatar., Gregory JM; Institute of Medical Sciences, University of Aberdeen, UK., Patani R; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, London, UK; Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK. Electronic address: rickie.patani@ucl.ac.uk. |
